Home  |  Contact

Cellosaurus UCRU-BL-17 (CVCL_M007)

[Text version]

Cell line name UCRU-BL-17
Synonyms UCRU-BL-17-CL; UCRU-BL-17CL; UCRU BL 17CL; UCRU-BL 17; BL-17; BL17
Accession CVCL_M007
Resource Identification Initiative To cite this cell line use: UCRU-BL-17 (RRID:CVCL_M007)
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_M008 (UCRU-BL-23)
Sex of cell Female
Age at sampling 69Y
Category Cancer cell line
Publications

PubMed=2418959
Russell P.J., Raghavan D., Gregory P., Philips J., Wills E.J., Jelbart M., Wass J., Zbroja R.A., Vincent P.C.
Bladder cancer xenografts: a model of tumor cell heterogeneity.
Cancer Res. 46:2035-2040(1986)

PubMed=3335421; DOI=10.1002/ijc.2910410115
Russell P.J., Jelbart M., Wills E., Singh S., Wass J., Wotherspoon J., Raghavan D.
Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.
Int. J. Cancer 41:74-82(1988)

PubMed=2685375; DOI=10.1016/S0022-5347(17)39172-3
Walker K.Z., Russell P.J., Kingsley E.A., Philips J., Raghavan D.
Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
J. Urol. 142:1578-1583(1989)

PubMed=2328200; DOI=10.1038/bjc.1990.81
Brown J.L., Russell P.J., Philips J., Wotherspoon J., Raghavan D.
Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.
Br. J. Cancer 61:369-376(1990)

PubMed=8635192; DOI=10.1007/BF01526554
Kingsley E.A., Carter T.E., Barrow K.D., Russell P.J.
Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Cancer Immunol. Immunother. 41:348-354(1995)

PubMed=8873383; DOI=10.1007/BF00295899
Stadler W.M., Olopade O.I.
The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
Urol. Res. 24:239-244(1996)

Patent=US5622836
Walker K.Z., Russell P.J.
Monoclonal antibodies which recognize malignant cells from bladder carcinomas.
Patent number US5622836, 22-Apr-1997

PubMed=9246190; DOI=10.1080/09553009714349
Ribeiro J.C.C., Barnetson A.R., Fisher R.J., Mameghan H., Russell P.J.
Relationship between radiation response and p53 status in human bladder cancer cells.
Int. J. Radiat. Biol. 72:11-20(1997)

PubMed=23401075; DOI=10.1002/path.4176
Guo Y., Chekaluk Y., Zhang J., Du J., Gray N.S., Wu C.-L., Kwiatkowski D.J.
TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
J. Pathol. 230:17-27(2013)

Cross-references
Other Wikidata; Q54989701
Polymorphism and mutation databases Cosmic; 735768
Cosmic; 928828
Cosmic; 1927311
Entry history
Entry creation06-May-2013
Last entry updated07-Sep-2018
Version number8